Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CRAI
CRAI logo

CRAI Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
159.090
Open
152.300
VWAP
154.19
Vol
107.62K
Mkt Cap
1000.00M
Low
148.100
Amount
16.59M
EV/EBITDA(TTM)
12.58
Total Shares
6.46M
EV
1.13B
EV/OCF(TTM)
--
P/S(TTM)
1.29
CRA International, Inc. is a global consulting firm specializing in providing economic, financial and management consulting services. It offers consulting services in two areas: litigation, regulatory, and financial consulting and management consulting. It provides consulting services to corporate clients and attorneys in a range of litigation and regulatory proceedings, providing research and analysis, expert testimony, and support in litigation and regulatory proceedings in all areas of finance, accounting, economics, insurance, and forensic accounting and investigations. It also uses its expertise in economics, finance, and business to offer law firms, businesses, and government agencies services. Its management consulting services include strategy development, performance improvement, corporate strategy and portfolio analysis, estimation of market demand, new product pricing strategies, survey and market research, valuation of intellectual property and other assets and others.
Show More

Events Timeline

(ET)
2026-05-07
08:20:00
CRA Reports Q1 Revenue of $201M
select
2026-05-07
08:20:00
Maleh Reaffirms Fiscal 2026 Revenue Guidance of $785M to $805M
select
2026-04-15 (ET)
2026-04-15
08:40:00
CRA International to Conduct Auction for FirstEnergy's Ohio Subsidiaries
select
2026-02-26 (ET)
2026-02-26
09:00:00
CRA Expands Share Repurchase Program to $55M
select
2026-02-26
09:00:00
CRA Reports Q4 Revenue of $196.96M, Sets Annual Record
select

News

Globenewswire
8.5
07-07Globenewswire
PinnedBriaCell Engages CRA for Bria-IMT Market Evaluation
  • Market Evaluation Partnership: BriaCell Therapeutics has engaged Charles River Associates (CRA) and Kaleio, Inc. to evaluate the epidemiology, pricing, and prescriber dynamics of Bria-IMT in the metastatic breast cancer market, thereby supporting brand strategies and enhancing market access potential.
  • Clinical Trial Progress: Bria-IMT is currently under evaluation in BriaCell's pivotal Phase 3 study, with ClinicalTrials.gov identifier NCT06072612, and is not yet commercially approved, laying the groundwork for future commercialization planning.
  • Commercial Readiness: This collaboration is viewed as a prudent step for BriaCell as it continues to assess Bria-IMT while preparing for potential commercialization discussions, indicating the company's focus on future market opportunities.
  • Innovative Treatment Development: BriaCell is dedicated to developing novel immunotherapies to transform cancer care, and as the evaluation of Bria-IMT progresses, it may present new growth opportunities for the company, further enhancing its competitiveness in the biotechnology sector.
Newsfilter
7.5
07-07Newsfilter
BriaCell Engages CRA and Kaleio for Market Access Evaluation of Bria-IMT
  • Market Evaluation Partnership: BriaCell Therapeutics has engaged Charles River Associates and Kaleio, Inc. to assess the pricing, prescriber dynamics, and market access potential for Bria-IMT in metastatic breast cancer, thereby supporting brand strategies and commercial readiness solutions.
  • Clinical Trial Progress: Bria-IMT is currently undergoing a pivotal Phase 3 clinical study (ClinicalTrials.gov identifier: NCT06072612), and while it is not yet commercially approved, the success of this study could pave the way for future market access.
  • Commercial Readiness Steps: This collaboration is viewed as a prudent step by BriaCell as it continues to evaluate Bria-IMT and prepares for potential commercialization planning and strategic discussions, reflecting the company's focus on future market opportunities.
  • Innovative Treatment Development: BriaCell is dedicated to developing novel immunotherapies to transform cancer care, and as Bria-IMT progresses through clinical trials, the company's competitive position and industry impact are expected to significantly enhance.
NASDAQ.COM
8.0
05-22NASDAQ.COM
CRAI Dividend Forecast and Stock Performance Analysis
  • Dividend Yield Analysis: CRAI's current estimated annualized dividend yield stands at 1.54%, and while dividends are not always predictable, historical data aids in assessing the likelihood of future dividends, thereby influencing investor return expectations.
  • Stock Price Range: CRAI's 52-week low is $132.17 and its high is $227.29, with the last trade at $148.89, indicating significant price fluctuations that may affect investor buying decisions based on perceived value.
  • Recent Stock Performance: On Friday, CRAI shares rose approximately 0.2%, reflecting short-term market confidence in the stock, which could attract more investor interest and potentially drive further price appreciation.
  • Technical Indicator Reference: Comparing the stock's performance against the 200-day moving average provides investors with a technical analysis framework, assisting them in evaluating CRAI's future trajectory and optimal investment timing.
Yahoo Finance
4.5
05-17Yahoo Finance
U.S. Producer Price Index Surges, Impacting Stocks
  • Producer Price Surge: The U.S. Bureau of Labor Statistics reported a 1.4% month-over-month increase in the Producer Price Index (PPI) for April, marking the largest monthly rise since March 2022, with a year-over-year increase of 6%, indicating persistent inflationary pressures that may lead companies to pass costs onto consumers, thereby increasing market uncertainty.
  • Market Reaction: Following this news, several stocks fell sharply, including CRA down 3.5%, SAIC down 4.5%, OSI Systems down 4.2%, EPAM down 3.9%, and Kyndryl down 4.8%, reflecting the market's sensitive response to inflation data and its implications for future earnings.
  • Kyndryl's Volatility: Kyndryl's shares have experienced over 20 moves greater than 5% in the past year, and while today's drop is significant, it suggests that the market perceives the news as impactful but not fundamentally altering its view of the business, indicating investor confidence in long-term contracts.
  • Investor Interest in IT Sector: As the threat of prolonged Middle East conflict recedes, enterprise clients are more likely to commit to multi-year digital transformation projects, and with moderating inflation expectations alongside falling oil prices, IT firms can better forecast wage and overhead expenses, driving renewed investor interest in the sector as a reliable growth play.
seekingalpha
9.5
05-07seekingalpha
CRA International Q1 Earnings Exceed Expectations
  • Earnings Performance: CRA International reported a Q1 Non-GAAP EPS of $1.99, missing expectations by $0.03; however, revenue reached $201.0 million, reflecting a 10.5% year-over-year increase and exceeding forecasts by $7.18 million, indicating robust growth in the market.
  • Revenue Target: The company outlined a revenue target of $785 million to $805 million for 2026, demonstrating confidence in future growth, particularly through ongoing investments in AI-driven consulting services.
  • Profitability Analysis: Although the Q1 Non-GAAP EPS was $2.06, slightly missing expectations by $0.01, the revenue of $197 million surpassed forecasts by $6.46 million, showcasing the company's ability to maintain strong profitability in a competitive landscape.
  • Market Rating: Seeking Alpha's Quant Rating on CRA International reflects a positive outlook from the market regarding its future performance, further bolstering investor confidence in the company's strategic direction.
NASDAQ.COM
8.0
04-25NASDAQ.COM
CRA International Stock Options Show High Implied Volatility
  • Options Market Volatility: The $135 call option for CRA International expiring on May 15, 2026, shows high implied volatility, indicating that the market anticipates significant price movement, potentially due to an upcoming event, warranting investor attention.
  • Analyst Estimate Changes: Over the past 60 days, two analysts have raised their earnings estimates for CRA International to $2.06 per share, reflecting a cautiously optimistic outlook on the company's future performance amidst fluctuating expectations.
  • Trading Strategy Impact: The high implied volatility attracts options traders, with many seasoned traders opting to sell options to capture time decay, hoping that the underlying stock will not move as much as initially expected by expiration.
  • Investor Focus: CRA International has been highlighted in a recent Zacks Investment Research report as a potential trading opportunity, which, combined with its ranking in the consulting services industry, may draw increased investor interest.
Wall Street analysts forecast CRAI stock price to rise
1 Analyst Rating
Wall Street analysts forecast CRAI stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
245.00
Averages
245.00
High
245.00
Current: 0.000
sliders
Low
245.00
Averages
245.00
High
245.00
Barrington
Barrington
Outperform
maintain
$235 -> $239
AI Analysis
2025-11-03
Reason
Barrington
Barrington
Price Target
$235 -> $239
AI Analysis
2025-11-03
maintain
Outperform
Reason
Barrington raised the firm's price target on Charles River Associates to $239 from $235 and keeps an Outperform rating on the shares. The company reported strong Q3 results and upped its 2025 outlook again, the analyst tells investors in a research note. The firm believes Charles River continues to execute its key capital allocation priority.
Barrington
Barrington
Outperform
maintain
$228 -> $235
2025-08-06
Reason
Barrington
Barrington
Price Target
$228 -> $235
2025-08-06
maintain
Outperform
Reason
Barrington raised the firm's price target on Charles River Associates to $235 from $228 and keeps an Outperform rating on the shares. The firm increased estimates following the "strong" Q4 report.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CRAI
Unlock Now

Valuation Metrics

The current forward P/E ratio for CRA International Inc (CRAI.O) is 17.21, compared to its 5-year average forward P/E of 20.69. For a more detailed relative valuation and DCF analysis to assess CRA International Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
20.69
Current PE
17.21
Overvalued PE
24.68
Undervalued PE
16.70

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
14.06
Current EV/EBITDA
16.22
Overvalued EV/EBITDA
16.43
Undervalued EV/EBITDA
11.70

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.38
Current PS
1.16
Overvalued PS
1.68
Undervalued PS
1.09

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what stocks will gain the most today
Intellectia · 38 candidates
Market Cap: >= 500.00MRegion: USPrice Change Pct: >= $0.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEOne Day Rise Prob: >= 70One Day Predict Return: >= 3.0%
Ticker
Name
Market Cap$
top bottom
CAC logo
CAC
Camden National Corp
839.62M
BAK logo
BAK
Braskem SA
1.49B
OUT logo
OUT
OUTFRONT Media Inc
4.20B
FBP logo
FBP
First BanCorp
3.51B
HLLY logo
HLLY
Holley Inc
503.73M
CFG logo
CFG
Citizens Financial Group Inc
27.81B
Best stocks to buy for gains
Intellectia · 11 candidates
Market Cap: >= 1000.00MDividend Yield Ttm: <= 3Relative Vol: >= 1.50Beta: ModerateRiskWeekly Average Turnover: >= 1,000,000Pe Ttm: <= 25Quarter Price Change Pct: >= $0.00Annual Eps Yoy Growth: >= 15.0%Annual Revenue Yoy Growth: >= 10.0%
Ticker
Name
Market Cap$
top bottom
MS logo
MS
Morgan Stanley
290.20B
AU logo
AU
Anglogold Ashanti PLC
51.18B
KGC logo
KGC
Kinross Gold Corp
43.05B
FTI logo
FTI
TechnipFMC PLC
21.93B
UMBF logo
UMBF
UMB Financial Corp
9.60B
EGO logo
EGO
Eldorado Gold Corp
9.02B

Whales Holding CRAI

R
Rice Hall James & Associates, LLC
Holding
CRAI
+9.36%
3M Return
C
Copeland Capital Management, LLC
Holding
CRAI
+6.17%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is CRA International Inc (CRAI) stock price today?

The current price of CRAI is 155.38 USD — it has increased 3.62

What is CRA International Inc (CRAI)'s business?

CRA International, Inc. is a global consulting firm specializing in providing economic, financial and management consulting services. It offers consulting services in two areas: litigation, regulatory, and financial consulting and management consulting. It provides consulting services to corporate clients and attorneys in a range of litigation and regulatory proceedings, providing research and analysis, expert testimony, and support in litigation and regulatory proceedings in all areas of finance, accounting, economics, insurance, and forensic accounting and investigations. It also uses its expertise in economics, finance, and business to offer law firms, businesses, and government agencies services. Its management consulting services include strategy development, performance improvement, corporate strategy and portfolio analysis, estimation of market demand, new product pricing strategies, survey and market research, valuation of intellectual property and other assets and others.

What is the price predicton of CRAI Stock?

Wall Street analysts forecast CRAI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CRAI is245.00 USD with a low forecast of 245.00 USD and a high forecast of 245.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is CRA International Inc (CRAI)'s revenue for the last quarter?

CRA International Inc revenue for the last quarter amounts to 200.97M USD, increased 10.52

What is CRA International Inc (CRAI)'s earnings per share (EPS) for the last quarter?

CRA International Inc. EPS for the last quarter amounts to 1.69 USD, decreased -35.50

How many employees does CRA International Inc (CRAI). have?

CRA International Inc (CRAI) has 959 emplpoyees as of July 08 2026.

What is CRA International Inc (CRAI) market cap?

Today CRAI has the market capitalization of 1000.00M USD.